Pierre Deharo

2.3k total citations
61 papers, 993 citations indexed

About

Pierre Deharo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Pierre Deharo has authored 61 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 18 papers in Epidemiology. Recurrent topics in Pierre Deharo's work include Cardiac Valve Diseases and Treatments (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Infective Endocarditis Diagnosis and Management (18 papers). Pierre Deharo is often cited by papers focused on Cardiac Valve Diseases and Treatments (27 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Infective Endocarditis Diagnosis and Management (18 papers). Pierre Deharo collaborates with scholars based in France, United Kingdom and United States. Pierre Deharo's co-authors include Thomas Cuisset, Arnaud Bisson, Jacques Quilici, Laurent Fourcade, Thibaud Lacour, Marie‐Christine Alessi, Pierre‐Emmanuel Morange, Guillaume Bonnet, Valentine Verdier and Julien Herbert and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and International Journal of Molecular Sciences.

In The Last Decade

Pierre Deharo

56 papers receiving 967 citations

Peers

Pierre Deharo
Pierre Deharo
Citations per year, relative to Pierre Deharo Pierre Deharo (= 1×) peers Paolo Cimaglia

Countries citing papers authored by Pierre Deharo

Since Specialization
Citations

This map shows the geographic impact of Pierre Deharo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Deharo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Deharo more than expected).

Fields of papers citing papers by Pierre Deharo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Deharo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Deharo. The network helps show where Pierre Deharo may publish in the future.

Co-authorship network of co-authors of Pierre Deharo

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Deharo. A scholar is included among the top collaborators of Pierre Deharo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Deharo. Pierre Deharo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bernard, Anne, Pierre Deharo, & Laurent Fauchier. (2024). Time matters when considering treatment for patients with mitral regurgitation. European Heart Journal. 45(33). 3091–3091.
3.
Deharo, Pierre, Jean‐François Obadia, Patrice Guérin, et al.. (2024). Mitral transcatheter edge-to-edge repair vs. isolated mitral surgery for severe mitral regurgitation: a French nationwide study. European Heart Journal. 45(11). 940–949. 11 indexed citations
4.
Kuno, Toshiki, Atsuyuki Watanabe, Satoshi Shoji, et al.. (2023). Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis. Circulation Cardiovascular Interventions. 16(9). e013242–e013242. 18 indexed citations
5.
Silva, Kalpa De, Abdul Mozid, Andrew Ladwiniec, et al.. (2023). The everolimus eluting Synergy MegatronTMdrug‐eluting stent platform: Early outcomes from the European Synergy MegatronTMImplanters' Registry. Catheterization and Cardiovascular Interventions. 102(7). 1222–1228. 2 indexed citations
6.
Théron, Alexis, Alizée Porto, Pierre Morera, et al.. (2022). Prosthesis–Patient Mismatch in Small Aortic Annuli: Self-Expandable vs. Balloon-Expandable Transcatheter Aortic Valve Replacement. Journal of Clinical Medicine. 11(7). 1959–1959. 9 indexed citations
7.
Deharo, Pierre, Thomas Cuisset, Arnaud Bisson, et al.. (2021). Outcomes Following Aortic Stenosis Treatment (Transcatheter vs Surgical Replacement) in Women vs Men (From a Nationwide Analysis). The American Journal of Cardiology. 154. 67–77. 4 indexed citations
8.
Shoji, Satoshi, Toshiki Kuno, Tomohiro Fujisaki, et al.. (2021). De-Escalation of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndromes. Journal of the American College of Cardiology. 78(8). 763–777. 42 indexed citations
9.
Deharo, Pierre, Arnaud Bisson, Julien Herbert, et al.. (2020). Transcatheter Valve-in-Valve Aortic Valve Replacement as an Alternative to Surgical Re-Replacement. Journal of the American College of Cardiology. 76(5). 489–499. 75 indexed citations
10.
Deharo, Pierre, Noémie Resseguier, Alizée Porto, et al.. (2020). Rapid deployment aortic-valve replacement versus trans-catheter aortic-valve replacement in intermediate-risk patients: A propensity score analysis. Archives of Cardiovascular Diseases Supplements. 12(1). 90–90.
12.
Lantelme, Pierre, Thibaud Lacour, Arnaud Bisson, et al.. (2020). Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation. The American Journal of Cardiology. 130. 100–107. 20 indexed citations
13.
Fauchier, Laurent, Arnaud Bisson, Julien Herbert, et al.. (2020). Incidence and outcomes of infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement. Clinical Microbiology and Infection. 26(10). 1368–1374. 35 indexed citations
14.
Grosdidier, Charlotte, Pierre Deharo, Denis Bernot, et al.. (2019). Platelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndrome. Research and Practice in Thrombosis and Haemostasis. 3(4). 684–694. 4 indexed citations
15.
Gaudry, Marine, Marion Marlinge, Pierre Deharo, et al.. (2019). Pharmacological profile of adenosine A2A receptors in patients with lower extremity peripheral artery disease and associated coronary artery disease: A pilot study. International Journal of Cardiology. 285. 121–127. 12 indexed citations
16.
Deharo, Pierre, Dominique Grisoli, Nicolas Jaussaud, et al.. (2018). Prosthesis patient mismatch is an independent predictor of congestive heart failure after transcatheter aortic valve replacement. Archives of Cardiovascular Diseases Supplements. 11(1). 65–66. 1 indexed citations
17.
Deharo, Pierre, Jacques Quilici, Laurence Camoin‐Jau, et al.. (2017). Benefit of Switching Dual Antiplatelet Therapy After Acute Coronary Syndrome According to On-Treatment Platelet Reactivity. JACC: Cardiovascular Interventions. 10(24). 2560–2570. 24 indexed citations
18.
Deharo, Pierre, Marina Ureña, Dominique Himbert, et al.. (2016). Bail-Out Alcohol Septal Ablation for Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. JACC: Cardiovascular Interventions. 9(8). e73–e76. 26 indexed citations
19.
Deharo, Pierre, François Silhol, Jean Michel Bartoli, et al.. (2016). Young Women with a Long Past of Resistant Hypertension Cured after Surgery of Severe Bilateral Ostial Renal Artery Stenosis. Annals of Vascular Surgery. 34. 272.e5–272.e8. 1 indexed citations
20.
Pankert, Mathieu, Jacques Quilici, Valentine Verdier, et al.. (2013). Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting. The American Journal of Cardiology. 113(1). 54–59. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026